addressalign-toparrow-leftarrow-rightbackbellblockcalendarcameraccwcheckchevron-downchevron-leftchevron-rightchevron-small-downchevron-small-leftchevron-small-rightchevron-small-upchevron-upcircle-with-checkcircle-with-crosscircle-with-pluscontroller-playcrossdots-three-verticaleditemptyheartexporteye-with-lineeyefacebookfolderfullheartglobegmailgooglegroupshelp-with-circleimageimagesinstagramFill 1light-bulblinklocation-pinm-swarmSearchmailmessagesminusmoremuplabelShape 3 + Rectangle 1ShapeoutlookpersonJoin Group on CardStartprice-ribbonprintShapeShapeShapeShapeImported LayersImported LayersImported Layersshieldstartickettrashtriangle-downtriangle-uptwitteruserwarningyahoo

Last chance to register for Marc Tessier-Lavigne event; other

From: John W.
Sent on: Wednesday, March 27, 2013 9:49 AM
Morning Biotechies,

1) There are just a few slots left for tomorrow's Marc Tessier-Lavigne. http://nycbiorockefeller.eventbrite.com/ if you haven't registered yet. If you come to one event this year, come to this one.

2) If there are particular questions you guys have for Marc, email me.

3) In talking with multiple companies especially of the diagnostic field, I've grown increasingly more concerned at the potential [unforeseen] outcomes of the Myriad case. In particular, while it's claimed eliminating gene patents would help research, it seems the model would shift toward secrecy over patenting (yea that'd help research...). I just added a new meetup "Gene patents, bio- and medtech" to discuss such possibilities. Not scheduled but please say you're coming if it's of interest. This may change diagnostics as we know it.

Best,

John
Founder
NYC Bio

People in this
Meetup are also in:

Sign up

Meetup members, Log in

By clicking "Sign up" or "Sign up using Facebook", you confirm that you accept our Terms of Service & Privacy Policy